Daily Briefing · 2026-08-07

Pharmacy

Lilly drops another gene therapy trial from $1B Prevail buyout

• Eli Lilly has axed another trial of a gene therapy acquired in its $1 billion Prevail Therapeutics buyout, further denting the drugmaker’s chances of delivering a return on its investment.

FierceBiotech ↗

Health OS

As AI use rises, younger adults skip preventive care, survey finds

• Online search, medical websites and social media are also used to manage health more than consulting providers among younger patients, the survey found.

Fierce Healthcare ↗

← All issues